UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Mather Group LLC.

Mather Group LLC. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,121 shares of the healthcare conglomerate’s stock after selling 282 shares during the period. Mather Group LLC.’s holdings in UnitedHealth Group were worth $2,994,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of UNH. Visionary Wealth Advisors grew its stake in shares of UnitedHealth Group by 3.2% during the fourth quarter. Visionary Wealth Advisors now owns 1,232 shares of the healthcare conglomerate’s stock valued at $649,000 after acquiring an additional 38 shares in the last quarter. MGO One Seven LLC raised its position in shares of UnitedHealth Group by 28.0% in the 4th quarter. MGO One Seven LLC now owns 8,760 shares of the healthcare conglomerate’s stock valued at $4,612,000 after purchasing an additional 1,917 shares in the last quarter. Rench Wealth Management Inc. grew its position in shares of UnitedHealth Group by 87.3% during the fourth quarter. Rench Wealth Management Inc. now owns 3,352 shares of the healthcare conglomerate’s stock worth $1,765,000 after buying an additional 1,562 shares in the last quarter. Ethic Inc. boosted its stake in UnitedHealth Group by 11.8% during the 4th quarter. Ethic Inc. now owns 72,396 shares of the healthcare conglomerate’s stock valued at $38,114,000 after acquiring an additional 7,645 shares during the last quarter. Finally, Putnam Investments LLC increased its position in shares of UnitedHealth Group by 3.9% in the 4th quarter. Putnam Investments LLC now owns 1,775,918 shares of the healthcare conglomerate’s stock worth $934,968,000 after purchasing an additional 66,180 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $581.56 on Wednesday. The company’s 50 day simple moving average is $582.58 and its 200 day simple moving average is $528.49. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a market capitalization of $537.02 billion, a PE ratio of 35.55, a P/E/G ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the business posted $6.14 earnings per share. The company’s quarterly revenue was up 6.4% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. Barclays boosted their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Royal Bank of Canada raised their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, September 25th. Wells Fargo & Company lifted their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Argus raised their target price on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.